ICAM1 and breast carcinoma: The curves indicated that the high expression levels of hsa-miR-19b, ICAM-1 and Integrin β1 (ITGB1) could significantly lower the survival rates for breast cancer patients compared with their low expression groups (p = 0.0092 for hsa-miR-19b curve, p = 0.0086 for ICAM-1 curve, p = 0.0062 for ITGB1 curve) (Figure 6A, 6D, 6E).